Sun Pharma Claims New Pill Distinct From Incyte's Hit Drug
Generic drugmaker Sun Pharma has asserted that its upcoming treatment for a hair loss condition wouldn't infringe on Incyte's intellectual property protections for a blockbuster drug treating autoimmune conditions, while also...To view the full article, register now.
Already a subscriber? Click here to view full article